DGX - QUEST DIAGNOSTICS INC


196.31
1.290   0.657%

Share volume: 1,960,225
Last Updated: 04-20-2026
Healthcare/Services – Health: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$195.02
1.29
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
55%
Profitability 46%
Dept financing 36%
Liquidity 67%
Performance 65%
Company vs Stock growth
vs
Performance
5 Days
2.53%
1 Month
0.36%
3 Months
6.31%
6 Months
6.32%
1 Year
21.28%
2 Year
50.90%
Key data
Stock price
$196.31
P/E Ratio 
19.37
DAY RANGE
$191.63 - $196.77
EPS 
$8.87
52 WEEK RANGE
$164.65 - $213.50
52 WEEK CHANGE
$13.58
MARKET CAP 
19.216 B
YIELD 
1.82%
SHARES OUTSTANDING 
109.866 M
DIVIDEND
$0.86
EX-DIVIDEND DATE
04-06-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.29
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,101,688
AVERAGE 30 VOLUME 
$890,152
Company detail
CEO: James E. Davis
Region: US
Website: questdiagnostics.com
Employees: 49,000
IPO year: 1996
Issue type: Common Stock
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic info services. It also provides risk assessment services for life insurance industry; and healthcare organizations and clinicians robust information technology solutions.

Recent news